Idex Corporation · NYSE:IEX

Idex — Q2 2012 Earnings Presentation

12 slides from Idex's earnings presentation, Jul 26, 2012

  1. Slide 1: Second Quarter 2012 Earnings Release

    Exhibit 99.1 Second Quarter 2012 Earnings Release July 24, 2012

  2. Slide 2: Agenda

    Agenda 2 • IDEX Mid Year Assessment • Q2 2012 Summary • 2012 Segment Performance Fluid & Metering Health & Science Fire & Safety / Diversified • 2012 Guidance Update • Q&A

  3. Slide 3: Replay Information

    Replay Information 3 Dial toll–free: 855.859.2056 International: 404.537.3406 Conference ID: #40917655 Log on to: www.idexcorp.com IDEX Proprietary & Confidential

  4. Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act

    4 Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward-looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause tho

  5. Slide 5: IDEX Mid-Year Assessment

    IDEX Mid-Year Assessment 5 Global Deceleration Strong first quarter followed by slowing second quarter North America remains strong for industrial and infrastructure-related markets Weak demand in Europe and slowing growth in China Growth rates in 2H will slow modestly Exceptional Operating Performa

  6. Slide 6: IDEX Q2 2012 Financial Performance

    IDEX Q2 2012 Financial Performance 6 Total Revenue EPS* Organic: 6% Growth 8% Growth Operating Margin* Free Cash Flow 30 bps expansion 54% Growth * EPS / Op Margin data adjusted for $2.6M restructuring expense (2012) and $3M CVI inventory step-up expense (2011) IDEX Proprietary & Confidential Contin

  7. Slide 7: Fluid & Metering

    Fluid & Metering 7 Total Orders Total Revenue Operating Margin* Organic: 2% Decline Organic: 3% Growth 220 bps expansion 22.1% $211 $202 $209 $211 25% $300 $300 19.9% $200 $200 20% $100 $100 15% $0 $0 10% Q2 Q2 Q2 2011 2012 2011 2012 2011 2012 Q2 Sales Mix:Organic +3% Q2 Summary: Order softness expe

  8. Slide 8: Health & Science

    Health & Science 8 Total Orders Total Revenue Operating Margin* Organic: 7% Growth Organic: 3% Growth 470 bps contraction 25% 21.3% $300 $300 $166 $171 $132 $140 20% 16.6% $200 $200 $100 $100 15% $0 $0 10% Q2 Q2 Q2 2011 2012 2011 2012 2011 2012 Q2 Sales Mix:Organic +3% Q2 Summary: Acquired Matcon LT

  9. Slide 9: Fire & Safety/Diversified

    Fire & Safety/Diversified 9 Total Orders Total Revenue Operating Margin* Organic: 3% Growth Organic: 15% Growth 210 bps contraction $116 30% 25.5% $150 $104 $102 $150 $105 23.4% $100 $100 20% $50 $50 $0 $0 10% Q2 Q2 Q2 2011 2012 2011 2012 2011 2012 Q2 Sales Mix:Organic +15% Q2 Summary: North America

  10. Slide 10: Outlook: Revised Guidance

    Outlook: Revised Guidance 10 FY12 Revenue Adjusted EPS April 2012 - Prior Guidance ~$2.0 B $2.80 - $2.85 Q2 miss (Compared to midpoint of prior guidance) (15) (0.04) Slower 2H Organic / Cost actions (30) (0.06) Optics (Challenging end markets) (10) (0.04) Fx impact (20) (0.03) ERC acquisition impact

  11. Slide 11: Outlook: 2012 Guidance Summary

    Outlook: 2012 Guidance Summary 11 Q3 2012 Adjusted EPS estimate range: $0.62 $0.64 – Organic revenue growth of ~ 3% Negative Fx impact of ~3% to sales (at June 30 rates) FY 2012 Adjusted EPS estimate range: $2.65 $2.70 – Organic revenue growth ~ 4-5% Positive impact of 4% from acquisitions Operating

  12. Slide 12: Q&A

    12 Q&A IDEX Proprietary & Confidential

Idex — Q2 2012 Earnings Presentation on 6ix